Edition:
United Kingdom

Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

575.80INR
10:22am GMT
Change (% chg)

Rs6.00 (+1.05%)
Prev Close
Rs569.80
Open
Rs570.10
Day's High
Rs579.00
Day's Low
Rs570.10
Volume
171,271
Avg. Vol
186,557
52-wk High
Rs848.30
52-wk Low
Rs566.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 5.01 March 20 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 5 5
(2) OUTPERFORM 8 9 9 9
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.60 1.80 1.80

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 1 5,299.00 5,299.00 5,299.00 --
Quarter Ending Sep-19 1 5,696.00 5,696.00 5,696.00 --
Year Ending Mar-19 13 22,707.20 24,918.00 20,796.00 27,592.20
Year Ending Mar-20 14 24,269.40 31,926.00 20,252.00 28,148.90
Earnings (per share)
Quarter Ending Jun-19 1 5.01 5.01 5.01 --
Quarter Ending Sep-19 1 6.79 6.79 6.79 --
Year Ending Mar-19 13 38.07 45.30 33.50 48.04
Year Ending Mar-20 15 38.12 58.84 21.64 41.81

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 5,611.20 5,567.00 44.20 0.79
Quarter Ending Sep-18 5,752.61 5,435.00 317.61 5.52
Quarter Ending Jun-18 6,516.60 5,386.00 1,130.60 17.35
Quarter Ending Mar-18 7,016.67 7,678.00 661.33 9.43
Quarter Ending Dec-17 6,705.67 5,622.00 1,083.67 16.16

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 5,299.00 5,299.00 5,299.00 5,299.00 --
Quarter Ending Sep-19 5,696.00 5,696.00 5,696.00 5,696.00 --
Year Ending Mar-19 22,707.20 23,940.80 23,940.80 24,392.00 27,592.20
Year Ending Mar-20 24,269.40 26,108.00 26,108.00 25,972.00 28,148.90

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 0 0 0 0
Quarter Ending Sep-19 0 0 0 0
Year Ending Mar-19 1 8 1 8
Year Ending Mar-20 2 7 2 7
Earnings